Cipla’s “Asthma Ke Liye, Inhalers Hain Sahi” campaign addresses the persistent stigma and misinformation surrounding asthma treatment in India by positioning inhalers as not only medically effective but socially acceptable and empowering. The campaign’s core promise is that inhalers enable individuals with asthma to overcome physical limitations and live fulfilling, aspirational lives—exemplified through the story of a young girl who pursues her dream of becoming a Kathak dancer despite her condition. This narrative framing humanizes asthma patients, shifting the focus from the disease’s restrictions to the possibilities unlocked by proper treatment.
The campaign strategically taps into deep-rooted cultural challenges, including widespread myths, social stigma, and limited asthma awareness, by leveraging an emotionally resonant and culturally meaningful story that integrates India’s classical dance heritage. Coupled with an original song by established artist Amit Trivedi, it enhances engagement and appeal across diverse demographic segments. By targeting not just patients but also their families and communities, the campaign seeks to normalize inhaler use and dispel fears that prevent adoption of this safe and effective treatment. The use of relatable storytelling in audio-visual formats helps build empathy and awareness, positioning Cipla’s BreatheFree initiative as a trusted resource.
Furthermore, the campaign underscores practical guidance (such as the use of spacers with inhalers for children) to foster informed usage, aligning with Cipla’s broader health education mission. Distributed through digital platforms, with significant viewership and community interaction, the campaign employs a narrative-driven approach rooted in both emotional connection and factual education to address a public health challenge in a culturally sensitive and impactful manner.
FORMAT#5 EXEMPLARY STORY — Tells a story where the product plays a vital role in the plot or resolution.
This campaign centers on the narrative of a young girl with asthma who dreams of becoming a Kathak dancer like her mother, facing a significant obstacle due to her illness. The plot follows her journey as she consistently uses inhalers, enabling her to overcome asthma’s limitations and achieve her aspirations. The inhaler is not merely present—it is the key agency that allows the protagonist to persist and ultimately realize her dream, anchoring the plot’s resolution. The story arc, use of generational ambition, and the emotional payoff all position the inhaler as the decisive, positive agent. Supported by a music video, emotional storytelling, and an aspirational protagonist, this campaign is a textbook example of the Exemplary Story format, where the product is the core enabler within the narrative, not just an add-on. For a further breakdown on advertising formats: https://www.clapboard.com/blog/branding-and-advertising/brand-strategy/12-advertising-creative-formats
1. Dr. Reddy’s Laboratories – Positioned as a patient-centric pharmaceutical company, Dr. Reddy’s leverages its strong R&D capabilities to provide affordable, high-quality respiratory and specialty medicines. They often emphasize accessibility and trust through a combination of innovation and generic drug offerings, targeting both urban and rural segments with a strong focus on chronic disease management in India.
2. GlaxoSmithKline (GSK) India – GSK positions itself as a trusted global pharmaceutical and consumer healthcare brand that combines scientific innovation with patient education. Their respiratory portfolio focuses on advanced inhaler technology and awareness campaigns, underlining quality, efficacy, and global standards to combat stigma around asthma treatments in Indian markets.
3. Novartis India – Novartis India differentiates by emphasizing innovation in respiratory care, incorporating cutting-edge inhaler devices and integrated patient support programs. Their positioning is backed by a strong global footprint and commitment to chronic disease management, focusing on improving patients’ quality of life through education and accessible therapies.
4. Mankind Pharma – Mankind Pharma leverages its reputation as a fast-growing, cost-effective pharmaceutical player focused on making healthcare affordable and accessible. Their strategic angle centers on broad reach and affordability in respiratory care, often targeting underserved populations through aggressive marketing and distribution networks.
5. Cipla – Cipla’s market positioning emphasizes its legacy as a pioneer in respiratory care, particularly asthma, with a strong commitment to educating patients and breaking social stigmas. Cipla combines affordability with innovation in inhaler technology, highlighted by initiatives like BreatheFree, promoting adherence and empowering patients to live active, unrestricted lives.
Q: What is Asthma Ke Liye, Inhalers Hain Sahi about?
A: Asthma Ke Liye, Inhalers Hain Sahi is a 2022 campaign created by Schbang for Cipla in the Indian healthcare market. The campaign tells the story of a young girl with asthma who aspires to become a Kathak dancer like her mother. Through consistent use of inhalers, she overcomes the physical challenges of her condition and achieves her dream. The narrative is brought to life in a music video featuring an original song by Amit Trivedi, aiming to destigmatize inhaler use and promote asthma awareness under Cipla’s BreatheFree initiative.
Q: What creative device does Asthma Ke Liye, Inhalers Hain Sahi use?
A: Asthma Ke Liye, Inhalers Hain Sahi employs the Exemplary Story format, as classified by Clapboard’s 12-format taxonomy. In this approach, the product—inhalers—plays a vital, active role in the plot’s resolution rather than serving as a passive backdrop. The campaign’s narrative centers on the protagonist’s journey, with the inhaler as the decisive agent enabling her to overcome asthma and fulfill her aspirations. This format ensures the product is integral to the story’s emotional and narrative payoff, aligning with best practices for story-driven health communication.
Q: What is the campaign proposition for Asthma Ke Liye, Inhalers Hain Sahi?
A: The strategic proposition of Asthma Ke Liye, Inhalers Hain Sahi is to position inhalers as the safe, effective, and socially acceptable treatment for asthma, directly challenging the stigma and misinformation prevalent in India. Cipla’s message targets not only asthma patients but also their families and communities, emphasizing that proper inhaler use enables individuals to lead active, aspirational lives. By embedding this message in a culturally resonant story and leveraging music and dance, the campaign seeks to normalize inhaler adoption and foster a more informed, supportive environment for asthma care.
Q: How does Asthma Ke Liye, Inhalers Hain Sahi rank in Clapboard's archive?
A: Asthma Ke Liye, Inhalers Hain Sahi holds a Clapboard Campaign Score of 73/100. This score reflects the campaign’s creative ambition, execution quality, and cultural relevance as evaluated by Clapboard’s global ad archive.
Q: Who are the competitors in Cipla's category?
A: In the Indian pharmaceutical and respiratory care sector, Cipla competes with Dr. Reddy’s Laboratories, which focuses on patient-centric, accessible respiratory medicines; GlaxoSmithKline (GSK) India, which leverages global innovation and education to promote advanced inhaler technology; Novartis India, known for cutting-edge devices and integrated patient support; and Mankind Pharma, which emphasizes affordability and broad market reach, especially among underserved populations. Each competitor brings a distinct positioning, shaping the landscape in which Cipla’s respiratory initiatives operate.
.webp)
